| Trial ID: | L0399 |
| Source ID: | NCT04692025
|
| Associated Drug: |
ASC41
|
| Title: |
A Randomized, Single Center, Open-label, Phase I Study to Evaluate the Effect of Food and Fasting on the Pharmacokinetics of ASC41 Tablets in Healthy Volunteers
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Healthy;NAFLD;Hyperlipidemia
|
| Interventions: |
Drug: ASC41 tablet
|
| Outcome Measures: |
AUC of ASC41;Cmax of ASC41t1/2 of ASC41;CL/F of ASC41;Vd/F of ASC41;Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
|
| Sponsor/Collaborators: |
Gannex Pharma Co., Ltd.
|
| Gender: |
All
|
| Age: |
18 Years45 Years
|
| Phases: |
Phase 1
|
| Enrollment: |
12
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
29/12/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 April 2021
|
| Locations: |
China
|
| URL: |
https://clinicaltrials.gov/show/NCT04692025
|
